Site

Neu-Ulm

The NUVISAN Clinical Hub

Satisfies all needs for Early Clinical Trials including PM, Monitoring, Medical Writing and CDM/STAT

Clinical is supported by API Synthesis, Bioanalysis with small/large molecules, cell-based assays, biomarkers and Clinical Trial Supplies.

Infrastructure

Headcount: 295 employees (42% university graduates)

1.305 m² Bioanalytical Capacity: 1.305 m²

Bed capacity: 140 (including Site Gauting)

Inspections & Authorizations

GMP certified (1989)

GLP certified (1994)

ANVISA certified (2005)

License to work with genetically modified organisms (S1)

History

Established in 1979

Started as LAB, changed to AAI and since 2010 NUVISAN GmbH

Today, NUVISAN is a fully integrated CRO/CDMO

Working Fields & Specialties

In-house CPU with 140 beds including PM, Monitoring, Medical writing and CDM/STAT

Bioanalysis with small and large molecules, cell-based assays and Biomakers

Safety lab

Clinical Trial Supplies: GMP Manufacturing and Packaging Services

API Synthesis

NUVISAN Service Lines

PHARMACEUTICAL

CLINICAL

ANALYTICAL